SK4032001A3 - Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes - Google Patents

Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes Download PDF

Info

Publication number
SK4032001A3
SK4032001A3 SK403-2001A SK4032001A SK4032001A3 SK 4032001 A3 SK4032001 A3 SK 4032001A3 SK 4032001 A SK4032001 A SK 4032001A SK 4032001 A3 SK4032001 A3 SK 4032001A3
Authority
SK
Slovakia
Prior art keywords
alkyl
substituted
amino
group
alkylamino
Prior art date
Application number
SK403-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Rainer Walter
Wolfgang Grell
Armin Heckel
Frank Himmelsbach
Wolfgang Eberlein
Gerald Roth
Meel Jacobus C A Van
Norbert Redemann
Walter Spevak
Ulrike Tontsch-Grunt
Ruden Thomas Von
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19844003A external-priority patent/DE19844003A1/de
Priority claimed from DE19937496A external-priority patent/DE19937496A1/de
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of SK4032001A3 publication Critical patent/SK4032001A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SK403-2001A 1998-09-25 1999-09-22 Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes SK4032001A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19844003A DE19844003A1 (de) 1998-09-25 1998-09-25 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
DE19937496A DE19937496A1 (de) 1999-08-07 1999-08-07 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
PCT/EP1999/007040 WO2000018734A1 (fr) 1998-09-25 1999-09-22 Nouvelles indolinones substituees a effet inhibiteur sur differentes kinases et differents complexes cycline/cdk

Publications (1)

Publication Number Publication Date
SK4032001A3 true SK4032001A3 (en) 2001-11-06

Family

ID=26049076

Family Applications (1)

Application Number Title Priority Date Filing Date
SK403-2001A SK4032001A3 (en) 1998-09-25 1999-09-22 Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes

Country Status (28)

Country Link
US (1) US6855710B2 (fr)
EP (1) EP1115704B1 (fr)
JP (1) JP2002525356A (fr)
KR (1) KR20010085841A (fr)
CN (1) CN1319090A (fr)
AT (1) ATE243195T1 (fr)
AU (1) AU763361B2 (fr)
BG (1) BG105327A (fr)
BR (1) BR9914065A (fr)
CA (1) CA2342622A1 (fr)
DE (1) DE59906030D1 (fr)
DK (1) DK1115704T3 (fr)
EA (1) EA200100320A1 (fr)
EE (1) EE200100184A (fr)
ES (1) ES2196860T3 (fr)
HR (1) HRP20010216A2 (fr)
HU (1) HUP0104973A3 (fr)
ID (1) ID27757A (fr)
IL (1) IL141622A0 (fr)
NO (1) NO20011477D0 (fr)
NZ (1) NZ510845A (fr)
PL (1) PL346898A1 (fr)
PT (1) PT1115704E (fr)
SI (1) SI1115704T1 (fr)
SK (1) SK4032001A3 (fr)
TR (1) TR200100854T2 (fr)
WO (1) WO2000018734A1 (fr)
YU (1) YU21301A (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9904933D0 (en) * 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
WO2003027102A1 (fr) * 2001-09-27 2003-04-03 Allergan, Inc. L'utilisation de 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones en tant qu'inhibiteurs de kinases
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
US6797825B2 (en) 2001-12-13 2004-09-28 Abbott Laboratories Protein kinase inhibitors
EA008830B1 (ru) 2002-03-26 2007-08-31 Бёрингер Ингельхайм Фармасьютиклз, Инк. Миметики глюкокортикоидов, способы их получения, фармацевтические композиции и их применение
US7169936B2 (en) 2002-07-23 2007-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments
US7514468B2 (en) 2002-07-23 2009-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions
DE10233366A1 (de) * 2002-07-23 2004-02-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel
PE20040701A1 (es) * 2002-07-23 2004-11-30 Boehringer Ingelheim Pharma Derivados de indolinona sustituidos en posicion 6 y su preparacion como medicamentos
DE10237423A1 (de) * 2002-08-16 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von LCK-Inhibitoren für die Behandlung von immunologischen Erkrankungen
US20040204458A1 (en) 2002-08-16 2004-10-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of Lck inhibitors for treatment of immunologic diseases
BR0313923A (pt) * 2002-08-29 2005-07-12 Boehringer Ingelheim Pharma Derivados de 3-(sulfonamidoetil)-indol para uso como miméticos de glicocorticóide no tratamento de doenças inflamatórias, alérgicas e proliferativas
US7148249B2 (en) * 2002-09-12 2006-12-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
JP4879492B2 (ja) * 2002-11-27 2012-02-22 アラーガン、インコーポレイテッド 疾患の治療のためのキナーゼ阻害剤
US20050043233A1 (en) 2003-04-29 2005-02-24 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
ATE414701T1 (de) * 2003-10-03 2008-12-15 Boehringer Ingelheim Pharma Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren
JP4861976B2 (ja) 2004-03-11 2012-01-25 アクテリオン ファーマシューティカルズ リミテッド インドール−1−イル酢酸誘導体
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
PE20061155A1 (es) * 2004-12-24 2006-12-16 Boehringer Ingelheim Int Derivados de indolinona como agentes para el tratamiento o la prevencion de enfermedades fibroticas
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
PE20060776A1 (es) 2004-12-27 2006-09-26 Boehringer Ingelheim Pharma Mimeticos de glucocorticoides, metodos para prepararlos y composiciones farmaceuticas
WO2006114371A1 (fr) 2005-04-28 2006-11-02 Boehringer Ingelheim International Gmbh Nouveaux composes destines au traitement de maladies inflammatoires
CN101547909A (zh) 2006-12-06 2009-09-30 贝林格尔.英格海姆国际有限公司 糖皮质激素模拟物、其制备方法、药物组合物及其用途
US20100086544A1 (en) * 2006-12-11 2010-04-08 Mass Robert D Compositions and methods for treating a neoplasm
CN101273991B (zh) * 2007-03-28 2010-05-26 广东同德药业有限公司 四氢吲哚酮/四氢吲唑酮/四氢咔唑衍生物及其盐在制备抗病毒药物中的应用
PE20091445A1 (es) 2007-12-03 2009-10-19 Boehringer Ingelheim Int Derivados de indolinona y procedimiento para su fabricacion
EP2229359B1 (fr) * 2007-12-03 2017-11-29 Boehringer Ingelheim International GmbH Procédé de fabrication d'un dérivé d'indolinone
ES2394239T3 (es) * 2008-01-25 2013-01-23 Boehringer Ingelheim International Gmbh Formas salinas de un derivado de 6-fluoro-1,2-dihidro-2-oxo-3H-indol-3-ilideno, procedimiento para su preparación y composiciones farmacéuticas que las contienen
JP2011524867A (ja) 2008-06-06 2011-09-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糖質コルチコイド模倣物質、その製造方法、医薬組成物、及びその使用
CA2731919A1 (fr) 2008-07-29 2010-02-04 Boehringer Ingelheim International Gmbh Nouveaux composes
JPWO2013137371A1 (ja) * 2012-03-15 2015-08-03 興和株式会社 新規ピリミジン化合物及びそれらを含有する医薬
CN103664737A (zh) * 2012-09-25 2014-03-26 杨子娇 一类治疗房角狭窄的化合物及其用途
EP3749697A4 (fr) 2018-02-05 2021-11-03 Bio-Rad Laboratories, Inc. Résine de chromatographie ayant un ligand mode mixte échange anionique/hydrophobe
CN114957084B (zh) * 2022-01-21 2023-05-09 九江学院 一种吲哚酮类化合物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501567D0 (en) * 1995-01-26 1995-03-15 Pharmacia Spa Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease

Also Published As

Publication number Publication date
NZ510845A (en) 2003-10-31
EA200100320A1 (ru) 2001-10-22
CA2342622A1 (fr) 2000-04-06
PT1115704E (pt) 2003-11-28
NO20011477L (no) 2001-03-22
ID27757A (id) 2001-04-26
DK1115704T3 (da) 2003-09-29
HUP0104973A3 (en) 2002-06-28
HUP0104973A2 (hu) 2002-04-29
EE200100184A (et) 2002-08-15
JP2002525356A (ja) 2002-08-13
BR9914065A (pt) 2001-06-19
YU21301A (sh) 2003-04-30
KR20010085841A (ko) 2001-09-07
AU6086399A (en) 2000-04-17
WO2000018734A1 (fr) 2000-04-06
PL346898A1 (en) 2002-03-11
ATE243195T1 (de) 2003-07-15
US6855710B2 (en) 2005-02-15
SI1115704T1 (en) 2003-12-31
AU763361B2 (en) 2003-07-17
EP1115704A1 (fr) 2001-07-18
TR200100854T2 (tr) 2001-12-21
DE59906030D1 (de) 2003-07-24
IL141622A0 (en) 2002-03-10
EP1115704B1 (fr) 2003-06-18
NO20011477D0 (no) 2001-03-22
US20040058978A1 (en) 2004-03-25
HRP20010216A2 (en) 2002-04-30
ES2196860T3 (es) 2003-12-16
BG105327A (en) 2001-12-29
CN1319090A (zh) 2001-10-24

Similar Documents

Publication Publication Date Title
SK4032001A3 (en) Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes
EP1212318B1 (fr) Indolinones substituees utilisees comme inhibiteurs de la tyrosine kinase
JP4015365B2 (ja) 新規な置換インドリノン、それらの調製及び医薬組成物としてのそれらの使用
US7173028B2 (en) Pyrimidine derivatives
CA2387013C (fr) Indolinones substituees en position 6, leur preparation et leur utilisation en tant que compositions pharmaceutiques
US6762180B1 (en) Substituted indolines which inhibit receptor tyrosine kinases
AU764782B2 (en) Substituted indolinones, the production thereof and their use as medicaments
US6638965B2 (en) Substituted indolinones, preparation thereof and their use as pharmaceutical compositions
US6169106B1 (en) Indolinones having kinase inhibitory activity
DE19844003A1 (de) Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
US6319918B1 (en) Substituted indolinones with kinase inhibitory activity
DE19937496A1 (de) Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
CZ20011080A3 (cs) Nové substituované indolinony s inhibičním účinkem na různé kinázy a komplexy cyklin/CKD
DE10042696A1 (de) In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
DE10029285A1 (de) Neue substituierte Indolinone,ihre Herstellung und ihre Verwendung als Arzneimittel
MXPA01002855A (en) Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes
DE19949208A1 (de) In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel